Silence Therapeutics Plc ADR
(SLN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,395 | -58,590 | -38,064 | -28,867 | -12,844 |
| Depreciation Amortization | 163 | 596 | 402 | 285 | 152 |
| Accounts receivable | -945 | -722 | 237 | -3,227 | -3,010 |
| Accounts payable and accrued liabilities | 509 | 1,790 | 4,418 | 915 | -4,158 |
| Other Working Capital | -8,834 | -9,600 | -3,559 | -6,270 | -10,407 |
| Other Operating Activity | 15,202 | 10,301 | -1,179 | 8,733 | 10,977 |
| Operating Cash Flow | $-9,301 | $-56,225 | $-37,746 | $-28,430 | $-19,290 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -173 | -161 | -113 | -71 |
| Purchase Of Investment | N/A | -19,945 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -7 | -371 | N/A | N/A | N/A |
| Other Investing Activity | 188 | -343 | 11 | 5 | 3 |
| Investing Cash Flow | $156 | $-20,461 | $-151 | $-108 | $-68 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 81 | 53,482 | 50,783 | 49 | N/A |
| Other Financing Activity | -58 | -235 | -132 | -122 | -63 |
| Financing Cash Flow | $23 | $53,247 | $50,651 | $-73 | $-63 |
| Exchange Rate Effect | -700 | 282 | 6,656 | 1,025 | 311 |
| Beginning Cash Position | 66,591 | 90,958 | 86,612 | 92,326 | 98,672 |
| End Cash Position | 56,769 | 67,802 | 106,022 | 64,740 | 79,562 |
| Net Cash Flow | $-9,822 | $-23,156 | $19,410 | $-27,586 | $-19,110 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,301 | -56,225 | -37,746 | -28,430 | -19,290 |
| Capital Expenditure | -33 | -173 | -161 | -113 | -71 |
| Free Cash Flow | -9,333 | -56,398 | -37,908 | -28,543 | -19,361 |